SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Nymox Pharmaceutical Corp – ‘20-F’ for 12/31/19

On:  Monday, 3/30/20, at 3:36pm ET   ·   For:  12/31/19   ·   Accession #:  1640334-20-668   ·   File #:  1-12033

Previous ‘20-F’:  ‘20-F’ on 3/29/19 for 12/31/18   ·   Next:  ‘20-F’ on 3/29/21 for 12/31/20   ·   Latest:  ‘20-F’ on 5/2/23 for 12/31/22

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/30/20  Nymox Pharmaceutical Corp         20-F       12/31/19  107:5.1M                                   Pubco Reporting … Inc/FA

Annual Report by a Foreign Non-Canadian Issuer   —   Form 20-F   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 20-F        Annual Report by a Foreign Non-Canadian Issuer      HTML    722K 
 4: EX-13.A     Annual or Quarterly Report to Security Holders      HTML     25K 
 5: EX-13.B     Annual or Quarterly Report to Security Holders      HTML     25K 
 2: EX-12.A     Statement re: Computation of Ratios                 HTML     30K 
 3: EX-12.B     Statement re: Computation of Ratios                 HTML     30K 
59: R1          Document and Entity Information                     HTML     54K 
92: R2          Consolidated Statements of Comprehensive Income     HTML     78K 
82: R3          Consolidated Statements of Financial Position       HTML     87K 
22: R4          Consolidated Statements of Financial Position       HTML     28K 
                (Parenthetical)                                                  
58: R5          Consolidated Statements of Cash Flow                HTML     93K 
91: R6          Consolidated Statements of Changes in Equity        HTML     73K 
81: R7          Business Activities and Basis of Presentation       HTML     37K 
21: R8          Going Concern Considerations                        HTML     30K 
60: R9          Significant Estimates                               HTML     28K 
97: R10         Significant Accounting Policies                     HTML     76K 
62: R11         New Accounting Standards and Interpretations        HTML     30K 
27: R12         Property and Equipment                              HTML     89K 
39: R13         Intangible Assets                                   HTML     29K 
96: R14         Accounts Payable and Accrued Liabilities            HTML     38K 
61: R15         Convertible Notes                                   HTML     40K 
26: R16         Operating Leases and Commitments                    HTML     42K 
38: R17         Share Capital                                       HTML     41K 
95: R18         Stock Options                                       HTML     51K 
63: R19         Share Based Compensation                            HTML     37K 
19: R20         Warrants                                            HTML     59K 
57: R21         Income Taxes                                        HTML     60K 
94: R22         Earnings Per Share                                  HTML     35K 
84: R23         Financial Instruments Fair Value Disclosures        HTML     29K 
18: R24         Finance Income and Finance Costs                    HTML     52K 
56: R25         Segment Disclosures                                 HTML     43K 
93: R26         Concentrations                                      HTML     32K 
83: R27         Related Party Transactions                          HTML     39K 
20: R28         Research and Development Expenses                   HTML     40K 
55: R29         Personnel Expenses                                  HTML     37K 
35: R30         Capital Disclosures and Financial Risk              HTML     29K 
24: R31         Foreign Exchange Risk                               HTML     28K 
64: R32         Credit Risk                                         HTML     30K 
98: R33         Interest Rate Risk                                  HTML     27K 
36: R34         Liquidity Risk                                      HTML     33K 
25: R35         Subsequent Events                                   HTML     28K 
65: R36         Significant Accounting Policies (Policies)          HTML    127K 
99: R37         Significant Accounting Policies (Tables)            HTML     29K 
37: R38         Property and Equipment (Tables)                     HTML     88K 
23: R39         Accounts Payable and Accrued Liabilities (Tables)   HTML     37K 
51: R40         Convertible Notes (Tables)                          HTML     35K 
16: R41         Commitments and Contingencies (Tables)              HTML     38K 
75: R42         Share Capital (Tables)                              HTML     36K 
85: R43         Stock Options (Tables)                              HTML     55K 
52: R44         Share Based Compensation (Tables)                   HTML     34K 
17: R45         Warrants (Tables)                                   HTML     55K 
76: R46         Income Taxes (Tables)                               HTML     65K 
86: R47         Earnings Per Share (Tables)                         HTML     33K 
53: R48         Finance Income and Finance Costs (Tables)           HTML     51K 
15: R49         Segment Disclosures (Tables)                        HTML     42K 
33: R50         Concentrations (Tables)                             HTML     31K 
47: R51         Related Party Transactions (Tables)                 HTML     35K 
101: R52         Research and Development Expenses (Tables)          HTML     39K  
68: R53         Personnel Expenses (Tables)                         HTML     36K 
32: R54         Liquidity risk (Tables)                             HTML     31K 
46: R55         Significant Accounting Policies (Details)           HTML     33K 
100: R56         Significant Accounting Policies (Details            HTML     28K  
                Narrative)                                                       
67: R57         New Accounting Standards and Interpretations        HTML     35K 
                (Details Narrative)                                              
34: R58         Property and Equipment (Details)                    HTML     60K 
45: R59         Property and Equipment (Details Narrative)          HTML     28K 
90: R60         Intangible Assets (Details Narrative)               HTML     38K 
79: R61         Accounts Payable and Accrued Liabilities (Details)  HTML     34K 
14: R62         Convertible Notes (Details)                         HTML     32K 
50: R63         Convertible Notes (Details Narrative)               HTML     40K 
88: R64         Operating Leases and Commitments (Details)          HTML     31K 
77: R65         Operating Leases and Commitments (Details 1)        HTML     34K 
12: R66         Operating Leases and Commitments (Details           HTML     40K 
                Narrative)                                                       
48: R67         Share Capital (Details)                             HTML     30K 
87: R68         Share Capital (Details Narrative)                   HTML     40K 
80: R69         Stock Options (Details)                             HTML     52K 
71: R70         Stock Options (Details 1)                           HTML     43K 
102: R71         Stock Options (Details Narrative)                   HTML     30K  
41: R72         Share Based Compensation (Details)                  HTML     34K 
28: R73         Share Based Compensation (Details Narrative)        HTML     38K 
74: R74         Warrants (Details)                                  HTML     48K 
105: R75         Warrants (Details Narrative)                        HTML     36K  
44: R76         Income Taxes (Details)                              HTML     43K 
31: R77         Income Taxes (Details 1)                            HTML     33K 
69: R78         Income Taxes (Details 2)                            HTML     84K 
106: R79         Income Taxes (Details Narrative)                    HTML     28K  
72: R80         Earnings Per Share (Details)                        HTML     31K 
103: R81         Financial Instruments Fair Value Disclosures        HTML     34K  
                (Details Narrative)                                              
42: R82         Finance Income and Finance Costs (Details)          HTML     47K 
29: R83         Segment Disclosures (Details)                       HTML     43K 
73: R84         Concentrations (Details)                            HTML     32K 
104: R85         Related Party Transactions (Details)                HTML     36K  
43: R86         Related Party Transactions (Details Narrative)      HTML     36K 
30: R87         Research and Development Expenses (Details)         HTML     41K 
70: R88         Personnel Expenses (Details)                        HTML     35K 
107: R89         Capital Disclosures and Financial Risk (Details     HTML     39K  
                Narrative)                                                       
89: R90         Foreign Exchange risk (Details Narrative)           HTML     28K 
78: R91         Credit risk (Details Narrative)                     HTML     34K 
13: R92         Interest rate risk (Details Narrative)              HTML     27K 
49: R93         Liquidity risk (Details)                            HTML     35K 
66: XML         IDEA XML File -- Filing Summary                      XML    195K 
40: EXCEL       IDEA Workbook of Financial Reports                  XLSX    101K 
 6: EX-101.INS  XBRL Instance -- nymx-20191231                       XML   1.64M 
 8: EX-101.CAL  XBRL Calculations -- nymx-20191231_cal               XML    146K 
 9: EX-101.DEF  XBRL Definitions -- nymx-20191231_def                XML    448K 
10: EX-101.LAB  XBRL Labels -- nymx-20191231_lab                     XML    907K 
11: EX-101.PRE  XBRL Presentations -- nymx-20191231_pre              XML    735K 
 7: EX-101.SCH  XBRL Schema -- nymx-20191231                         XSD    307K 
54: ZIP         XBRL Zipped Folder -- 0001640334-20-000668-xbrl      Zip    133K 




        
Filing Submission 0001640334-20-000668 – SGML Text

Original SGML Text submitted by:  Pubco Reporting Solutions, Inc./FA  (as Filing Agent) 

To view the SGML, please refresh
Refresh emoji
this page.


Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 4:33:55.2pm ET